Compassionate Use Study of Tenalisib (RP6530)
NCT03711604
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Hematological Malignancies
Interventions
DRUG:
Tenalisib
Sponsor
Rhizen Pharmaceuticals SA